Mecasermin
From Wikipedia, the free encyclopedia
 |
This article does not cite any references or sources. (April 2008) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
|
Mecasermin
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | ? |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
C(US) |
| Legal status | |
| Routes | Subcutaneous |
Mecasermin, also known as mecasermin rinfabate (brand names Increlex and Iplex) is a growth hormone which is used for the long-term treatment of growth failure in children with severe primary IGF-1 deficiency.
|
|||||||||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
